Technology

LYMA

In 2018 LYMA launched the world’s most advanced nutraceutical, heralding a new era for the supplement industry.

Date of investment
December 2018
Cost of investment
£2,000,000
% of ownership
19.7%
Latest valuation of Pembroke investment
£31,200,000

LYMA was founded in February 2017 with an aspiration to develop a luxury wellness brand. The company worked closely with industry experts and the world’s leading nutritional scientists, combining intensive R&D with the latest technological advances to produce a unique, high-quality, evidence-based dietary supplement. As a result, LYMA’s game-changing formula is the most scientifically validated nutraceutical ever made, clinically proven to actively tackle inflammation, the root cause of ageing and disease.

The efficacy and credibility of LYMA’s product have earned recognition and praise from academic institutions such as Oxford University. LYMA’s formula incorporates patented ingredients carefully dosed at active levels to ensure optimal effectiveness. In addition, the extensive research supporting these ingredients and their dosages is derived from over 200 clinical trials published in peer-reviewed journals, further attesting to the scientific rigour behind LYMA’s approach.

By combining scientific expertise, cutting-edge research, and a commitment to excellence, LYMA has established itself as a leader in evidence-based nutrition. The brand aims to provide consumers with a premium, trustworthy, and effective supplement that targets inflammation and promotes overall health and longevity. LYMA’s dedication to scientific validation and collaboration with field experts contribute to its reputation as a reliable and innovative wellness brand.

Get in touch

We strive to provide the best possible support. If you have any questions, concerns, or feedback, please don't hesitate to reach out to us.

Contact us